GreenLight Biosciences Revenue and Competitors

Claim your profile

Boston, MA USA



Growjo Ranking



Estimated Revenue & Valuation

  • GreenLight Biosciences's estimated annual revenue is currently $84.2M per year.(i)
  • GreenLight Biosciences received $Undisclosed in venture funding in January 2019.
  • GreenLight Biosciences's estimated revenue per employee is $217,000
  • GreenLight Biosciences's total funding is $340.5M.

Employee Data

  • GreenLight Biosciences has 388 Employees.(i)
  • GreenLight Biosciences grew their employee count by 25% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

GreenLight Biosciences is a privately-held biotechnology company focused on sustainable production of chemicals and fuels using its patented Cell free bioprocessing technology platform. This revolutionary technology enables the biological conversion of economical, renewable substrates to valuable products with unprecedented flexibility and control.

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Solar Power,Wind Power


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





GreenLight Biosciences News

2022-04-06 - Are Institutions Heavily Invested In GreenLight Biosciences Holdings' (NASDAQ:GRNA) Shares?

GreenLight Biosciences Holdings has a market capitalization of US$1.1b, so we would expect some institutional investors to have noticed the...

2022-03-30 - GreenLight Biosciences: Synthesizing Cell-Free RNA

GreenLight Biosciences makes affordable and accessible RNA products for human health and agriculture. · The company's cell-free RNA manufacturing...

2022-03-22 - GreenLight Biosciences Shares Rise 15% After New Addition to Scientific Advisory Board

GreenLight Biosciences Holdings PBC shares were up 15% to $10.50 after the company said it named Barney Graham to its Human Health...

2021-08-11 - Environmental Impact Acquisition : Press Release, dated August 10, 2021 (Form 8-K)

GreenLight Biosciences announces business agreement with Environmental Impact Acquisition Corp. to become publicly traded company, allowing it to better harness its breakthrough platform to develop and produce RNA for human therapies and agriculture • GreenLight Biosciences, Inc. to become pub ...

2021-08-10 - Brief: GreenLight Biosciences agrees to go public in $1.2bn SPAC merger

GreenLight Biosciences, an ag biotech company using the RNA technology made famous by Covid-19 vaccines, has agreed to merge with a special purpose acquisition company (SPAC) in a deal that will value the company at $1.2 billion and list it on the Nasdaq [disclosure: AgFunder, AFN’s parent compa ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

GreenLight Biosciences Funding

DateAmountRoundLead InvestorsReference
2015-07-23$UndisclosedCMLS Capital FundArticle
2019-01-09$50.0MUndisclosedS2G VenturesArticle